Tevas Global Regulatory Affairs Policy and Intelligence team is at the forefront of regulatory policy and intelligence, transforming complex regulatory landscape updates into actionable insights to inform regulatory strategy and cross-functional strategic decision-making.
M.B.B.S OR Graduate in Health Sciences B.D.S, B.A.M.S, B.H.M.S, B.U.M.S, B.P.TH, Nursing Basic P.B.Bsc, B.PHARM, MPH, MHA, MBA in Health Care Administration.
Masters degree in Microbiology, Biotechnology, Chemical Engineering, Natural, Agricultural Sciences, MVSc or bachlors degree in Engineering or Technology or Medicine from a recognized University
Promote pharma product portfolio to healthcare professionals and institutions. Develop and maintain strong relationships with doctors, pharmacists, and key opinion leaders. Achieve sales targets and ensure market growth in the assigned territory.
Bachelors Degree in Pharmacy from a recognized institute. OR Diploma in Pharmacy. Community candidates from HIV infected and affected as well as key communities.
Provide strategic guidance and expertise in oncology for the development and execution of medical affairs plans focusing on Lung Cancer, GU Cancers and Hematology portfolio. Collaborate with cross-functional teams to support the successful launch and commercialization of oncology products.
The candidate is expected to perform cell biology, molecular biology, biochemistry experiments etc. e.g. cell culture, flow cytometry, immunofluorece imaging, western blotting. RT-PCR experiments annotate and analyse data.
GPAT is a national level examination for award of scholarship to qualified candidates seeking entry into Master of Pharmacy (M. Pharm) course. The first GPAT was conducted in the year 2010 and thereafter it is conducted every year till 2018 by All India Council for Technical Education (AICTE) as per the directions of Ministry of Education, Government of India and from the year 2019, the examination is conducted through the National Testing Agency (NTA) as per the directions of Ministry of Education, Government of India to till 2023.